Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Durez

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Journal of the Belgian Society of Radiology|January 28, 2022
MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease ActivityThomas Kirchgesner, Maria Stoenoiu, Patrick Durez, et al.
Diagnostic and Interventional Imaging|February 15, 2021
Contrast-enhanced T1-weighted Dixon water- and fat-only images to assess osteitis and erosions according to RAMRIS in hands of patients with early rheumatoid arthritisThomas Kirchgesner, Maria Stoenoiu, Nicolas Michoux, et al.
Joint Bone Spine|March 6, 2024
Sexual dysfunction in male patients treated with methorexate for arthritis: Analysis of the IIEF5 questionnaire and hormonal statusFrancesco Natalucci, Sandra Bisseron, Tatiana Sokolova, et al.
Immunotherapy|December 6, 2021
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilarEnrico Fusaro, Patrick Durez, Johannes Wohlrab, et al.
The Journal of Rheumatology|August 17, 2014
Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registryFilip De Keyser, Ilse Hoffman, Patrick Durez, et al.
The Journal of Rheumatology|June 3, 2014
Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort studyFilip De Keyser, Joris De Kock, Hermine Leroi, et al.
Biochemia Medica|August 11, 2020
A rare case of tuberculosis-induced hypercalcemiaLoris Wauthier, Xavier Theunssens, Patrick Durez, et al.
BMC Rheumatology|April 14, 2022
Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE studyPatrick Durez, Rene Westhovens, Femke Baeke, et al.
Acta Clinica Belgica|April 23, 2017
Efficacy of golimumab in Belgian patients with active rheumatoid arthritis despite treatment with non-biologic disease-modifying anti-rheumatic drugs: sub-analysis of the GO-MORE studyPatrick Durez, Marie Vanthuyne, Muhammad S Soyfoo, et al.
Annals of the Rheumatic Diseases|December 16, 2006
Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritisPatrick Durez, Virginie Fraselle, Frédéric Houssiau, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Journal of the Belgian Society of Radiology|January 28, 2022
MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease ActivityThomas Kirchgesner, Maria Stoenoiu, Patrick Durez, et al.
Diagnostic and Interventional Imaging|February 15, 2021
Contrast-enhanced T1-weighted Dixon water- and fat-only images to assess osteitis and erosions according to RAMRIS in hands of patients with early rheumatoid arthritisThomas Kirchgesner, Maria Stoenoiu, Nicolas Michoux, et al.
Joint Bone Spine|March 6, 2024
Sexual dysfunction in male patients treated with methorexate for arthritis: Analysis of the IIEF5 questionnaire and hormonal statusFrancesco Natalucci, Sandra Bisseron, Tatiana Sokolova, et al.
Immunotherapy|December 6, 2021
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilarEnrico Fusaro, Patrick Durez, Johannes Wohlrab, et al.
The Journal of Rheumatology|August 17, 2014
Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registryFilip De Keyser, Ilse Hoffman, Patrick Durez, et al.
The Journal of Rheumatology|June 3, 2014
Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort studyFilip De Keyser, Joris De Kock, Hermine Leroi, et al.
Biochemia Medica|August 11, 2020
A rare case of tuberculosis-induced hypercalcemiaLoris Wauthier, Xavier Theunssens, Patrick Durez, et al.
BMC Rheumatology|April 14, 2022
Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE studyPatrick Durez, Rene Westhovens, Femke Baeke, et al.
Acta Clinica Belgica|April 23, 2017
Efficacy of golimumab in Belgian patients with active rheumatoid arthritis despite treatment with non-biologic disease-modifying anti-rheumatic drugs: sub-analysis of the GO-MORE studyPatrick Durez, Marie Vanthuyne, Muhammad S Soyfoo, et al.
Annals of the Rheumatic Diseases|December 16, 2006
Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritisPatrick Durez, Virginie Fraselle, Frédéric Houssiau, et al.
Pageof 12